Literature DB >> 21557112

Chronic liver inflammation and hepatocellular carcinoma: persistence matters.

Achim Weber1, Yannick Boege, Florian Reisinger, Mathias Heikenwälder.   

Abstract

Inflammatory responses in the liver--a central constituent of hepatic wound healing--can be self-limited or persistent depending on the aetiology, liver health state, concentration of toxins or pathogens, and the time frame of exposure to toxins or infection. In case the immune system eradicates a pathogen or in case toxin-exposure is transient, acute hepatitis resolves and the affected liver tissue regenerates ad integrum. However, in many cases liver damage remains chronic. Irrespective of the aetiology, chronic liver damage drives chronic hepatitis and hepatocyte death as well as compensatory proliferation, reflecting liver regeneration. Over time this potentially promotes further hepatic damage, fibrosis, cirrhosis and liver cancer. Here, we review the current knowledge on how chronic liver injury and inflammation is triggered and maintained, and how inflammation is linked to liver cancer. We also discuss the most frequently used animal models for damage or inflammation induced liver cancer and their suitability for conducting clinically relevant research.

Entities:  

Mesh:

Year:  2011        PMID: 21557112     DOI: 10.4414/smw.2011.13197

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  35 in total

Review 1.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

Review 2.  Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.

Authors:  Jimmy K Stauffer; Anthony J Scarzello; Qun Jiang; Robert H Wiltrout
Journal:  Hepatology       Date:  2012-09-11       Impact factor: 17.425

Review 3.  Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.

Authors:  Takashi Yamaguchi; Katsunori Yoshida; Miki Murata; Koichi Matsuzaki
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 4.  Prognostic value of red blood cell distribution width in hepatocellular carcinoma.

Authors:  Hemant Goyal; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2017-07

5.  Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.

Authors:  Cuiying Xiao; Rui-Hong Wang; Tyler J Lahusen; Ogyi Park; Adeline Bertola; Takashi Maruyama; Della Reynolds; Qiang Chen; Xiaoling Xu; Howard A Young; Wan-Jun Chen; Bin Gao; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

6.  The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study.

Authors:  Gundula Behrens; Charles E Matthews; Steven C Moore; Neal D Freedman; Katherine A McGlynn; James E Everhart; Albert R Hollenbeck; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2013-01-26       Impact factor: 8.082

7.  Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.

Authors:  Yuan Chen; Xiulong Song; Leila Valanejad; Alexander Vasilenko; Vijay More; Xi Qiu; Weikang Chen; Yurong Lai; Angela Slitt; Matthew Stoner; Bingfang Yan; Ruitang Deng
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

8.  Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.

Authors:  Wei-Dong Chen; Donna Yu; Barry M Forman; Wendong Huang; Yan-Dong Wang
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

9.  Hepatitis B virus upregulates cellular inhibitor of apoptosis protein 2 expression via the PI3K/AKT/NF-κB signaling pathway in liver cancer.

Authors:  Jianping Lian; Yuanhua Zou; Ling Huang; Hao Cheng; Kai Huang; Junquan Zeng; Longhua Chen
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

10.  Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.

Authors:  Ling Yang; Sayaka Inokuchi; Yoon Seok Roh; Jingyi Song; Rohit Loomba; Eek Joong Park; Ekihiro Seki
Journal:  Gastroenterology       Date:  2013-02-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.